Je was op zoek naar: antracicline (Roemeens - Engels)

chimioterapiei cu antracicline.
anthracycline-containing chemotherapy.

pacienți tratați anterior cu antracicline
anthracycline pre-treated patients

doxorubicina şi alte antracicline pot determina cardiotoxicitate.
doxorubicin and other anthracyclines can cause cardiotoxicity.

toxicitate cardiacă doxorubicina şi alte antracicline pot determina cardiotoxicitate.
cardiac toxicity doxorubicin and other anthracyclines can cause cardiotoxicity.

sunt necesare precauţii la pacienţii care au fost trataţi cu alte antracicline.
caution must be observed in patients who have received other anthracyclines.

riscul cardiotoxicitaţii este mai mare când herceptin este utilizat în asociere cu antracicline.
all candidates for treatment should undergo careful cardiac monitoring (see “ cardiotoxicity” section below). the risk of cardiotoxicity is greatest when herceptin is used in combination with anthracyclines.

Șaptezeci și șapte la sută dintre pacienți fuseseră expuși anterior la antracicline.
seventy-seven percent of the patients had been previously exposed to anthracyclines.

tratamentul anterior cu antracicline poate creşte riscul de apariţie a prelungirii intervalului qt.
previous treatment with anthracyclines may increase the risk of qt prolongation.

riscul toxicității cardiace crește cu creșterea acumulării dozelor de antracicline, inclusiv doxorubicina.
the risk of cardiac toxicity rises with increasing cumulative doses of anthracyclines, including doxorubicin.

acesta poate reduce gradul de vătămare a ţesuturilor cauzată de extravazarea provocată de antracicline.
it can reduce the amount of tissue damage caused by anthracycline extravasation.

pacienţii trataţi cu antracicline după oprirea tratamentului cu herceptin pot prezenta risc crescut de disfuncţie cardiacă.
patients who receive anthracyclines after stopping herceptin may possibly be at increased risk of cardiac dysfunction.

docetaxel plus trastuzumab a fost eficace la paciente, indiferent dacă au primit sau nu terapie adjuvantă cu antracicline.
docetaxel plus trastuzumab was efficacious in patients whether or not they had received prior adjuvant anthracyclines.

docetaxel plus trastuzumab a fost eficace la paciente, indiferent dacă primiseră sau nu terapie adjuvantă prealabilă cu antracicline.
docetaxel plus trastuzumab was efficacious in patients whether or not they had received prior adjuvant anthracyclines.

restul (25%) au utilizat anterior tratament combinat cu săruri de platină şi fluoropirimidină cu antracicline.
the remainder (25%) received prior platinum and fluoropyrimidine combination therapy with anthracycline.

substan a activă din caelyx, clorhidratul de doxorubicină, este un medicament citotoxic care apar ine grupei de „antracicline”.
the active substance in caelyx, doxorubicin hydrochloride, is a cytotoxic medicine that belongs to the group ‘anthracyclines’.

terapia anterioară trebuie să fi inclus o antraciclină.
previous therapy should have included an anthracycline.